Platelet inhibition and anticoagulation in endovascular neurosurgery

Sabih T. Effendi; Sricharan Gopakumar; Peter Kan

doi:10.1016/B978-0-12-811740-8.00021-6

Platelet inhibition and anticoagulation in endovascular neurosurgery

Sabih T. Effendi, Sricharan Gopakumar, Peter Kan

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Achieving an appropriate level of platelet inhibition and anticoagulation is crucial to avoid complications of thrombosis, embolism, and hemorrhage in neuroendovascular procedures. Numerous newer platelet inhibitors and anticoagulants have been released, recently. Additionally, many new laboratory and point-of-care (POC) tests are available on the market to determine the amount of platelet inhibition and anticoagulation. This chapter reviews the most commonly used platelet inhibitors, anticoagulants, and platelet function and anticoagulation tests for neuroendovascular procedures. We also discuss the use of these medications in the most common clinical scenarios.

Original language	English (US)
Title of host publication	Intracranial Aneurysms
Publisher	Elsevier
Pages	305-318
Number of pages	14
ISBN (Electronic)	9780128117408
ISBN (Print)	9780128118832
DOIs	https://doi.org/10.1016/B978-0-12-811740-8.00021-6
State	Published - Jan 1 2018
Externally published	Yes

Keywords

Acetylsalicylic acid
Anticoagulants
Aspirin
Clopidogrel
Direct factor Xa inhibitors
Direct thrombin inhibitors
GP IIb/IIIa inhibitors
Heparin
P2Y12 inhibitors
Platelet inhibitors
Plavix

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-12-811740-8.00021-6

Cite this

@inbook{95ce5dbea00840639db1a4b5f20b699e,

title = "Platelet inhibition and anticoagulation in endovascular neurosurgery",

abstract = "Achieving an appropriate level of platelet inhibition and anticoagulation is crucial to avoid complications of thrombosis, embolism, and hemorrhage in neuroendovascular procedures. Numerous newer platelet inhibitors and anticoagulants have been released, recently. Additionally, many new laboratory and point-of-care (POC) tests are available on the market to determine the amount of platelet inhibition and anticoagulation. This chapter reviews the most commonly used platelet inhibitors, anticoagulants, and platelet function and anticoagulation tests for neuroendovascular procedures. We also discuss the use of these medications in the most common clinical scenarios.",

keywords = "Acetylsalicylic acid, Anticoagulants, Aspirin, Clopidogrel, Direct factor Xa inhibitors, Direct thrombin inhibitors, GP IIb/IIIa inhibitors, Heparin, P2Y12 inhibitors, Platelet inhibitors, Plavix",

author = "Effendi, {Sabih T.} and Sricharan Gopakumar and Peter Kan",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-811740-8.00021-6",

language = "English (US)",

isbn = "9780128118832",

pages = "305--318",

booktitle = "Intracranial Aneurysms",

publisher = "Elsevier",

}

TY - CHAP

T1 - Platelet inhibition and anticoagulation in endovascular neurosurgery

AU - Effendi, Sabih T.

AU - Gopakumar, Sricharan

AU - Kan, Peter

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Achieving an appropriate level of platelet inhibition and anticoagulation is crucial to avoid complications of thrombosis, embolism, and hemorrhage in neuroendovascular procedures. Numerous newer platelet inhibitors and anticoagulants have been released, recently. Additionally, many new laboratory and point-of-care (POC) tests are available on the market to determine the amount of platelet inhibition and anticoagulation. This chapter reviews the most commonly used platelet inhibitors, anticoagulants, and platelet function and anticoagulation tests for neuroendovascular procedures. We also discuss the use of these medications in the most common clinical scenarios.

AB - Achieving an appropriate level of platelet inhibition and anticoagulation is crucial to avoid complications of thrombosis, embolism, and hemorrhage in neuroendovascular procedures. Numerous newer platelet inhibitors and anticoagulants have been released, recently. Additionally, many new laboratory and point-of-care (POC) tests are available on the market to determine the amount of platelet inhibition and anticoagulation. This chapter reviews the most commonly used platelet inhibitors, anticoagulants, and platelet function and anticoagulation tests for neuroendovascular procedures. We also discuss the use of these medications in the most common clinical scenarios.

KW - Acetylsalicylic acid

KW - Anticoagulants

KW - Aspirin

KW - Clopidogrel

KW - Direct factor Xa inhibitors

KW - Direct thrombin inhibitors

KW - GP IIb/IIIa inhibitors

KW - Heparin

KW - P2Y12 inhibitors

KW - Platelet inhibitors

KW - Plavix

UR - http://www.scopus.com/inward/record.url?scp=85083211756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083211756&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-811740-8.00021-6

DO - 10.1016/B978-0-12-811740-8.00021-6

M3 - Chapter

AN - SCOPUS:85083211756

SN - 9780128118832

SP - 305

EP - 318

BT - Intracranial Aneurysms

PB - Elsevier

ER -

Platelet inhibition and anticoagulation in endovascular neurosurgery

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this